$NXGL
NEXGEL, INC. Stock $nxgl

$nxgl Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017348 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$1.167M	$620.0K
YoY Change	108.02%	56.57%
Cost Of Revenue	$992.0K	$677.0K
YoY Change	115.65%	61.96%
Gross Profit	$175.0K	-$57.00K
YoY Change	73.27%	159.09%
Gross Profit Margin	15.0%	-9.19%
Selling, General & Admin	$882.0K	$797.0K
YoY Change	24.58%	4.05%
% of Gross Profit	504.0%
Research & Development	$55.00K	$29.00K
YoY Change	-50.45%	20.83%
% of Gross Profit	31.43%
Depreciation & Amortization	$37.00K	$31.00K
YoY Change	27.59%	10.71%
% of Gross Profit	21.14%
Operating Expenses	$937.0K	$826.0K
YoY Change	14.41%	4.56%
Operating Profit	-$762.0K	-$883.0K
YoY Change	6.13%	8.74%
Interest Expense	$9.000K	$72.00K
YoY Change	-102.82%	-108.24%
% of Operating Profit
Other Income/Expense, Net	$120.0K	$76.00K
YoY Change	-137.85%	-107.42%
Pretax Income	-$642.0K	-$807.0K
YoY Change	-37.97%	-56.05%
Income Tax
% Of Pretax Income
Net Earnings	-$695.0K	-$814.0K
YoY Change	-32.85%	-55.66%
Net Earnings / Revenue	-59.55%	-131.29%
Basic Earnings Per Share	-$0.12	-$0.15
Diluted Earnings Per Share	-$0.12	-$0.15
COMMON SHARES
Basic Shares Outstanding	5.614M shares	5.611M shares
Diluted Shares Outstanding	5.662B shares	5.586B shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.303M	$5.803M
YoY Change	-56.05%	-44.84%
Cash & Equivalents	$3.691M	$787.0K
Short-Term Investments	$612.0K	$5.016M
Other Short-Term Assets	$366.0K	$129.0K
YoY Change	16.93%	-22.75%
Inventory	$1.079M	$968.0K
Prepaid Expenses
Receivables	$950.0K	$380.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$6.698M	$7.280M
YoY Change	-37.9%	-34.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.413M	$1.282M
YoY Change	100.71%	83.67%
Goodwill	$311.0K	$311.0K
YoY Change	0.0%	0.0%
Intangibles	$13.00K	$16.00K
YoY Change	-50.0%	-46.67%
Long-Term Investments
YoY Change
Other Assets	$95.00K	$95.00K
YoY Change	-15.93%	50.79%
Total Long-Term Assets	$3.799M	$3.726M
YoY Change	27.23%	24.99%
TOTAL ASSETS
Total Short-Term Assets	$6.698M	$7.280M
Total Long-Term Assets	$3.799M	$3.726M
Total Assets	$10.50M	$11.01M
YoY Change	-23.77%	-21.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.058M	$987.0K
YoY Change	102.68%	439.34%
Accrued Expenses	$370.0K	$328.0K
YoY Change	26.71%	24.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$15.00K	$15.00K
YoY Change	-16.67%	7.14%
Total Short-Term Liabilities	$1.672M	$1.522M
YoY Change	-32.88%	-15.63%
LONG-TERM LIABILITIES
Long-Term Debt	$265.0K	$266.0K
YoY Change	0.76%	0.38%
Other Long-Term Liabilities	$1.819M	$1.864M
YoY Change	8.99%	9.2%
Total Long-Term Liabilities	$2.084M	$2.130M
YoY Change	7.87%	8.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.672M	$1.522M
Total Long-Term Liabilities	$2.084M	$2.130M
Total Liabilities	$3.756M	$3.652M
YoY Change	-15.08%	-3.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.07M	-$12.37M
YoY Change	34.95%	43.06%
Common Stock	$6.000K	$6.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.181M	$6.847M
YoY Change
Total Liabilities & Shareholders Equity	$10.50M	$11.01M
YoY Change	-23.77%	-21.83%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$695.0K	-$814.0K
YoY Change	-32.85%	-55.66%
Depreciation, Depletion And Amortization	$37.00K	$31.00K
YoY Change	27.59%	10.71%
Cash From Operating Activities	-$1.217M	-$709.0K
YoY Change	74.36%	-11.38%
INVESTING ACTIVITIES
Capital Expenditures	$165.0K	$88.00K
YoY Change	-632.26%
Acquisitions		$500.0K
YoY Change
Other Investing Activities	$4.287M	$485.0K
YoY Change	-179.82%
Cash From Investing Activities	$4.122M	$397.0K
YoY Change	-176.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.000K	-$2.000K
YoY Change		-99.9%
NET CHANGE
Cash From Operating Activities	-1.217M	-$709.0K
Cash From Investing Activities	4.122M	$397.0K
Cash From Financing Activities	-1.000K	-$2.000K
Net Change In Cash	2.904M	-$314.0K
YoY Change	-147.61%	-88.92%
FREE CASH FLOW
Cash From Operating Activities	-$1.217M	-$709.0K
Capital Expenditures	$165.0K	$88.00K
Free Cash Flow	-$1.382M	-$797.0K
YoY Change	107.2%	-0.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001468929
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	us-gaap	Other Income OtherIncome		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q1	NXGL	Noncontrolling Interest NoncontrollingInterest		usd
CY2022Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments		usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	NXGL	Property And Equipment Contributed As Capital Investment To Jv PropertyAndEquipmentContributedAsCapitalInvestmentToJv		usd
CY2022Q1	NXGL	Rou Asset And Operating Lease Liabilities Recognized Upon Consolidation Of Jv RouAssetAndOperatingLeaseLiabilitiesRecognizedUponConsolidationOfJv		usd
CY2022Q1	NXGL	Revenue From Finished Goods RevenueFromFinishedGoods		usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q1	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2023Q1	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41173
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NexGel, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-4042544
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2150 Cabot Blvd West
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite B
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Langhorne
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19047
CY2023Q1	dei	City Area Code CityAreaCode	(215)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	702-8550
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5614028	shares
CY2023Q1	us-gaap	Cash Cash	787000	usd
CY2022Q4	us-gaap	Cash Cash	1101000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5016000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5508000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	380000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	222000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	968000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	502000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	129000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	172000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	7280000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7505000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	311000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	311000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1282000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	721000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2022000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1737000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	95000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	63000	usd
CY2023Q1	us-gaap	Assets Assets	11006000	usd
CY2022Q4	us-gaap	Assets Assets	10357000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	987000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	265000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	112000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	130000	usd
CY2023Q1	NXGL	Notes Payable Excluding Convertible Notes Payable Current NotesPayableExcludingConvertibleNotesPayableCurrent	15000	usd
CY2022Q4	NXGL	Notes Payable Excluding Convertible Notes Payable Current NotesPayableExcludingConvertibleNotesPayableCurrent	15000	usd
CY2023Q1	NXGL	Warrant Liability Current WarrantLiabilityCurrent	176000	usd
CY2022Q4	NXGL	Warrant Liability Current WarrantLiabilityCurrent	242000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	232000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1522000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	859000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1864000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1593000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	266000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	268000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3652000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2720000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5614028	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5614028	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5577916	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5577916	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19213000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19189000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12372000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11558000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6847000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7637000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	507000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7354000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7637000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11006000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10357000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	620000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	396000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	677000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	418000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-57000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-22000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	797000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	766000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	826000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	790000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-883000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-812000	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1000	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	744000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-150000	usd
CY2023Q1	NXGL	Change In Fair Value Of Warrant Liability And Warrant Modification Expense ChangeInFairValueOfWarrantLiabilityAndWarrantModificationExpense	-66000	usd
CY2022Q1	NXGL	Change In Fair Value Of Warrant Liability And Warrant Modification Expense ChangeInFairValueOfWarrantLiabilityAndWarrantModificationExpense	130000	usd
CY2023Q1	NXGL	Gain On Investment In Marketable Securities GainOnInvestmentInMarketableSecurities	7000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	4000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	76000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1024000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-807000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1836000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-807000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1836000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-814000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1836000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5586326000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5572234000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5586326000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5572234000	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7637000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	24000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	500000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-807000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7354000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7354000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12085000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12085000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	55000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1836000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1836000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10304000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10304000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-814000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1836000	usd
CY2023Q1	NXGL	Noncontrolling Interest NoncontrollingInterest	7000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28000	usd
CY2023Q1	NXGL	Change In Right Of Use Asset And Operating Lease Liability ChangeInRightOfUseAssetAndOperatingLeaseLiability	11000	usd
CY2022Q1	NXGL	Change In Right Of Use Asset And Operating Lease Liability ChangeInRightOfUseAssetAndOperatingLeaseLiability	10000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	24000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	55000	usd
CY2023Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-7000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-66000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	130000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	741000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-150000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	158000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-77000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	466000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	722000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-71000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-18000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-709000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-797000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	485000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	88000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	397000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2033000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2033000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-314000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2830000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1101000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13350000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	787000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10520000	usd
CY2023Q1	NXGL	Property And Equipment Contributed As Capital Investment To Jv PropertyAndEquipmentContributedAsCapitalInvestmentToJv	500000	usd
CY2023Q1	NXGL	Rou Asset And Operating Lease Liabilities Recognized Upon Consolidation Of Jv RouAssetAndOperatingLeaseLiabilitiesRecognizedUponConsolidationOfJv	334000	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-35 reverse stock split
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Cash Cash	787000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5000000.0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-814000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-709000	usd
CY2023Q1	NXGL	Working Capital Deficit WorkingCapitalDeficit	5800000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zufFwkJOnmb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zNk7sYyUdMw5">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates and assumptions include allowances for doubtful accounts, inventory reserves, deferred taxes, share-based compensation and related valuation allowances and fair value of long-lived assets. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Marketable Securities MarketableSecurities	5016000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	5508000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	19000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	9000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	28000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	63000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	101000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	109000	usd
CY2023Q1	us-gaap	Marketable Securities MarketableSecurities	5016000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	5508000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y10M24D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.035	pure
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	65000	usd
CY2023Q1	NXGL	Revenue From Contract Manufacturing RevenueFromContractManufacturing	380000	usd
CY2022Q1	NXGL	Revenue From Contract Manufacturing RevenueFromContractManufacturing	135000	usd
CY2023Q1	NXGL	Revenue From Finished Goods RevenueFromFinishedGoods	4000	usd
CY2023Q1	NXGL	Revenue From Consumer Products RevenueFromConsumerProducts	222000	usd
CY2022Q1	NXGL	Revenue From Consumer Products RevenueFromConsumerProducts	213000	usd
CY2023Q1	NXGL	Revenue Classified As Others RevenueClassifiedAsOthers	14000	usd
CY2022Q1	NXGL	Revenue Classified As Others RevenueClassifiedAsOthers	48000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	620000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	396000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	61000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	184000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	245000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	245000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	301000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	315000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1115000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2405000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	309000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2096000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	721000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	27000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	54000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	582000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	295000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	63000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	51000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	323000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	156000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	968000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	502000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	968000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	502000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1904000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1315000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	622000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	594000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1282000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	25000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	56000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	58000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	52000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	112000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	130000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	542469	shares
CY2023Q1	NXGL	Warrant To Purchase Common Stock WarrantToPurchaseCommonStock	3557190	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	121787	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.5764	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0421	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	55000	usd
CY2023Q1	NXGL	Unrecognized Share Based Compensation Expense UnrecognizedShareBasedCompensationExpense	116000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3637190	shares
CY2022Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	5.16281
CY2023Q1	NXGL	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	30430000	shares
CY2023Q1	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice	0.69
CY2023Q1	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled	-49570000	shares
CY2023Q1	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Cancelled Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice	1.18
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3557190	shares
CY2023Q1	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	5.256569
CY2023Q1	NXGL	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1	P3Y5M19D
CY2023Q1	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	3557190	shares
CY2023Q1	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	5.256569
CY2023Q1	NXGL	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y5M19D
CY2023Q1	NXGL	Class Of Warrant Or Right Outstanding Intrinsic Value ClassOfWarrantOrRightOutstandingIntrinsicValue	90000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	500000	usd
CY2023Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	281000	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	283000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	4000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	256000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	281000	usd
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1680000	usd
CY2023Q1	NXGL	Stock Issued During Period Share Warrants Exercised StockIssuedDuringPeriodShareWarrantsExercised	-30430000	shares
CY2023Q1	NXGL	Exercise Of Warrants ExerciseOfWarrants	-54000	usd
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	335000	usd

Files In Submission

Name	View Source	Status
nxgl-20230331_pre.xml	Edgar Link	unprocessable
0001493152-23-017348-index-headers.html	Edgar Link	pending
0001493152-23-017348-index.html	Edgar Link	pending
0001493152-23-017348.txt	Edgar Link	pending
0001493152-23-017348-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nxgl-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nxgl-20230331_cal.xml	Edgar Link	unprocessable
nxgl-20230331_def.xml	Edgar Link	unprocessable
nxgl-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXGL
NEXGEL, INC. Stock $nxgl

2023 Q2 Form 10-Q Financial Statement

#000149315223017348 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXGL NEXGEL, INC. Stock $nxgl

2023 Q2 Form 10-Q Financial Statement

#000149315223017348 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXGL
NEXGEL, INC. Stock $nxgl